Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evanthia Galanis

Showing results (51-60 of 196) with videos related to

Pageof 20
Sort By:
Molecular Therapy. Oncology|January 16, 2026
Repurposing the SSRI paroxetine increases lymphocyte mobilization and improves the efficacy of measles virus-based immunovirotherapyGeorgios M Stergiopoulos, Susanna C Concilio, Kim B Viker, et al.
Cancer Research|August 17, 2002
Intraperitoneal therapy of ovarian cancer using an engineered measles virusKah-Whye Peng, Cynthia J TenEyck, Evanthia Galanis, et al.
Journal of Spinal Disorders & Techniques|July 20, 2002
Vertebra plana caused by primary Ewing sarcoma: case report and review of the literaturePanayiotis J Papagelopoulos, Bradford L Currier, Evanthia Galanis, et al.
Journal of Clinical Pharmacology|May 16, 2015
Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposureAlexander K Berg, Jan C Buckner, Evanthia Galanis, et al.
Neuro-Oncology|March 15, 2006
Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methodsEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
Virus Research|December 17, 2025
Replication competent La Crosse virus pseudotyped VSV vector system as vaccine and serological diagnostic reagentIanko Iankov, Arun Ammayappan, Kimberly Viker, et al.
Journal of Neuro-Oncology|June 1, 2017
Radiation-agent combinations for glioblastoma: challenges in drug development and future considerationsCharles A Kunos, Evanthia Galanis, Jeffrey Buchsbaum, et al.
Molecular Therapy Oncolytics|November 4, 2020
Live Attenuated Measles Virus Vaccine Expressing <i>Helicobacter</i> <i>pylori</i> Heat Shock Protein AIanko D Iankov, Cheyne Kurokawa, Kimberly Viker, et al.
Neuro-Oncology Practice|August 7, 2019
Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in OncologyJane H Cerhan, S Keith Anderson, Alissa M Butts, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
HSR26-206: The Future of Oncology Research: Replacing Case Report Forms With mCODE-Aligned Electronic Health Record Data for Clinical Trial Data Curation (Alliance)Amye J Tevaarwerk, Nancy Campbell, Hamid Emamekhoo, et al.
Pageof 20

Showing results (51-60 of 196) with videos related to

Sort By:
Pageof 20
Molecular Therapy. Oncology|January 16, 2026
Repurposing the SSRI paroxetine increases lymphocyte mobilization and improves the efficacy of measles virus-based immunovirotherapyGeorgios M Stergiopoulos, Susanna C Concilio, Kim B Viker, et al.
Cancer Research|August 17, 2002
Intraperitoneal therapy of ovarian cancer using an engineered measles virusKah-Whye Peng, Cynthia J TenEyck, Evanthia Galanis, et al.
Journal of Spinal Disorders & Techniques|July 20, 2002
Vertebra plana caused by primary Ewing sarcoma: case report and review of the literaturePanayiotis J Papagelopoulos, Bradford L Currier, Evanthia Galanis, et al.
Journal of Clinical Pharmacology|May 16, 2015
Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposureAlexander K Berg, Jan C Buckner, Evanthia Galanis, et al.
Neuro-Oncology|March 15, 2006
Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methodsEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
Virus Research|December 17, 2025
Replication competent La Crosse virus pseudotyped VSV vector system as vaccine and serological diagnostic reagentIanko Iankov, Arun Ammayappan, Kimberly Viker, et al.
Journal of Neuro-Oncology|June 1, 2017
Radiation-agent combinations for glioblastoma: challenges in drug development and future considerationsCharles A Kunos, Evanthia Galanis, Jeffrey Buchsbaum, et al.
Molecular Therapy Oncolytics|November 4, 2020
Live Attenuated Measles Virus Vaccine Expressing <i>Helicobacter</i> <i>pylori</i> Heat Shock Protein AIanko D Iankov, Cheyne Kurokawa, Kimberly Viker, et al.
Neuro-Oncology Practice|August 7, 2019
Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in OncologyJane H Cerhan, S Keith Anderson, Alissa M Butts, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
HSR26-206: The Future of Oncology Research: Replacing Case Report Forms With mCODE-Aligned Electronic Health Record Data for Clinical Trial Data Curation (Alliance)Amye J Tevaarwerk, Nancy Campbell, Hamid Emamekhoo, et al.
Pageof 20